A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors
Trial ID or NCT#
NCT05219981
Status
NOT RECRUITING
Purpose
In this study, patients with advanced solid tumors will undergo [18F]F AraG PET/CT imaging to assess for changes in tracer uptake following treatment with CkIT.
Official Title
A Pilot Study of Using [18F]F AraG PET Imaging to Evaluate the Immunological Response to Checkpoint Inhibitor Therapy (CkIT) in Patients With Advanced Solid Tumors
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - Solid tumor with planned CkIT - Must be >18 years old - Signed Informed Consent Form - Patient must have two qualifying lesions
Exclusion Criteria:
- - Patient is pregnant or breast feeding
Investigator(s)
David S. Wang, MD
Interventional radiologist,
Radiologist,
Minimally invasive surgeon,
Diagnostic radiologist
Clinical Associate Professor, Radiology
Nam Quoc Bui
Medical oncologist,
Sarcoma specialist
Clinical Assistant Professor, Medicine - Oncology
George A. Fisher Jr.
Medical oncologist,
Gastrointestinal specialist
Colleen Haas Chair in the School of Medicine
Contact us to find out if this trial is right for you.
Contact
Maria Isabel Galvez Leonio
650-723-0371
View on ClinicalTrials.gov
